Comparison of Clinical Effect of AcuPulse Micro-Carved Dot Matrix CO2 Laser With Alma Flyton UVB308nm on Alopecia Areata Treatment Under Dermoscopy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032179

Enrollment

Unknown

Registered

2020-04-22

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia areata

Interventions

Group 1:AcuPulse Micro-Carved Dot Matrix CO2 Laser

Group 2:Alma Flyton UVB308nm

Eligibility

Sex/Gender

All

Age

10 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. All patients who meet the diagnostic criteria for alopecia areata; 2. The area of hair loss does not exceed 30% of the area of the scalp; 3. The age is between 10 and 60 years old; 4. The patient has not received other treatment within 1 month.

Exclusion criteria

Exclusion criteria: 1. Those with pseudoalopecia areata, cicatricial alopecia, hair loss due to tinea capitis, syphilis, and leprosy; 2. Those who have been treated with immunosuppressive agents and glucocorticoids within the past month; 3. Those who are allergic to ultraviolet light therapy; 4. Lactating and pregnant women; 5. People with severe heart, liver and kidney diseases and other autoimmune diseases; 6. People with severe mental diseases; 7. People with congenital rarity or alopecia; 8. Unable to persist Treatment and follow-up.

Design outcomes

Primary

Measure	Time frame
SALT;	—

Countries

China

Contacts

Public ContactDou Lili

Gansu Provincial Hospital of TCM

doullzi@163.com+86 13993143432

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026